Chongqing Lummy Pharmaceutical Co.,Ltd. Posted 64 Million Yuan Net Loss in First Three Quarters of 2023

Chongqing Lummy Pharmaceutical Co.,Ltd. (重庆莱美药业股份有限公司) (300006.SZ) reported a net loss of 64 million yuan in the first three quarters of 2023, widening 43% year-on-year.

Meanwhile, the company posted 644.8 million yuan in revenue, down 3.9% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 787.8 million yuan in total liabilities, with a liability-to-asset ratio of 27.2%.